| Year |
Citation |
Score |
| 2014 |
Nagarajan RP, Zhang B, Bell RJ, Johnson BE, Olshen AB, Sundaram V, Li D, Graham AE, Diaz A, Fouse SD, Smirnov I, Song J, Paris PL, Wang T, Costello JF. Recurrent epimutations activate gene body promoters in primary glioblastoma. Genome Research. 24: 761-74. PMID 24709822 DOI: 10.1101/Gr.164707.113 |
0.388 |
|
| 2011 |
Deshmukh H, Yu J, Shaik J, MacDonald TJ, Perry A, Payton JE, Gutmann DH, Watson MA, Nagarajan R. Identification of transcriptional regulatory networks specific to pilocytic astrocytoma. Bmc Medical Genomics. 4: 57. PMID 21745356 DOI: 10.1186/1755-8794-4-57 |
0.303 |
|
| 2011 |
Jones EA, Lopez-Anido C, Srinivasan R, Krueger C, Chang LW, Nagarajan R, Svaren J. Regulation of the PMP22 gene through an intronic enhancer. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 31: 4242-50. PMID 21411665 DOI: 10.1523/Jneurosci.5893-10.2011 |
0.321 |
|
| 2010 |
Maunakea AK, Nagarajan RP, Bilenky M, Ballinger TJ, D'Souza C, Fouse SD, Johnson BE, Hong C, Nielsen C, Zhao Y, Turecki G, Delaney A, Varhol R, Thiessen N, Shchors K, et al. Conserved role of intragenic DNA methylation in regulating alternative promoters. Nature. 466: 253-7. PMID 20613842 DOI: 10.1038/Nature09165 |
0.421 |
|
| 2009 |
Nagarajan RP, Costello JF. Epigenetic mechanisms in glioblastoma multiforme. Seminars in Cancer Biology. 19: 188-97. PMID 19429483 DOI: 10.1016/j.semcancer.2009.02.005 |
0.34 |
|
| 2009 |
Swanberg SE, Nagarajan RP, Peddada S, Yasui DH, LaSalle JM. Reciprocal co-regulation of EGR2 and MECP2 is disrupted in Rett syndrome and autism. Human Molecular Genetics. 18: 525-34. PMID 19000991 DOI: 10.1093/Hmg/Ddn380 |
0.743 |
|
| 2008 |
Nagarajan RP, Patzel KA, Martin M, Yasui DH, Swanberg SE, Hertz-Picciotto I, Hansen RL, Van de Water J, Pessah IN, Jiang R, Robinson WP, LaSalle JM. MECP2 promoter methylation and X chromosome inactivation in autism. Autism Research : Official Journal of the International Society For Autism Research. 1: 169-78. PMID 19132145 DOI: 10.1002/Aur.24 |
0.598 |
|
| 2007 |
Yasui DH, Peddada S, Bieda MC, Vallero RO, Hogart A, Nagarajan RP, Thatcher KN, Farnham PJ, Lasalle JM. Integrated epigenomic analyses of neuronal MeCP2 reveal a role for long-range interaction with active genes. Proceedings of the National Academy of Sciences of the United States of America. 104: 19416-21. PMID 18042715 DOI: 10.1073/Pnas.0707442104 |
0.597 |
|
| 2007 |
Hogart A, Nagarajan RP, Patzel KA, Yasui DH, Lasalle JM. 15q11-13 GABAA receptor genes are normally biallelically expressed in brain yet are subject to epigenetic dysregulation in autism-spectrum disorders. Human Molecular Genetics. 16: 691-703. PMID 17339270 DOI: 10.1093/Hmg/Ddm014 |
0.703 |
|
| 2006 |
Nagarajan RP, Hogart AR, Gwye Y, Martin MR, LaSalle JM. Reduced MeCP2 expression is frequent in autism frontal cortex and correlates with aberrant MECP2 promoter methylation. Epigenetics : Official Journal of the Dna Methylation Society. 1: e1-11. PMID 17486179 DOI: 10.4161/epi.1.4.3514 |
0.707 |
|
| 2004 |
Samaco RC, Nagarajan RP, Braunschweig D, LaSalle JM. Multiple pathways regulate MeCP2 expression in normal brain development and exhibit defects in autism-spectrum disorders. Human Molecular Genetics. 13: 629-39. PMID 14734626 DOI: 10.1093/Hmg/Ddh063 |
0.635 |
|
| Show low-probability matches. |